Full Answer
A cardiolipin antibodies test looks for a certain kind of antibody in your blood. The antibodies are IgG (immunoglobulin G), IgA (immunoglobulin A), and IgM (immunoglobulin M). They are antibodies that form in response to cardiolipins. Cardiolipin is a phospholipid, or a kind of fat in the blood.
- Moderately or very high levels of anticardiolipin antibodies that persist for 12 weeks or more indicate a continued presence of these autoantibodies and an increased risk of abnormal clots and miscarriages.
A cardiolipin antibodies test looks for a certain kind of antibody in your blood. An antibody is a substance in your blood that helps fight off infection. The antibodies attack cardiolipins by mistake. Cardiolipin is a phospholipid, or a kind of fat in the blood that is important for blood clotting.
ICD-10 code D68. 61 for Antiphospholipid syndrome is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
The cardiolipin antibodies blood test, IgA, IgG, and IgM is used to help investigate inappropriate blood clot formation, to help determine the cause of recurrent miscarriage, or as part of an evaluation for antiphospholipid syndrome or sometimes other autoimmune diseases.
Anticardiolipins are antibodies produced by the immune system against the platelet membrane phospholipids responsible for the coagulation of blood clots.
IgG Cardiolipin antibodies: Negative : <10.0 GPL U/ml. Weak Positive : 10.0-40.0 GPL U/ml. Positive: >40 GPL U/ml.
Cardiolipin antibodies are the most common antiphospholipid antibody, a group of autoantibodies associated with excessive clotting and autoimmune diseases, such as lupus. They are frequently detected with other antiphospholipid antibodies, such as lupus anticoagulant and anti-beta-2 glycoprotein 1.
Antiphospholipid antibody with hemorrhagic disorder D68. 312 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D68. 312 became effective on October 1, 2021.
Antiphospholipid (AN-te-fos-fo-LIP-id) syndrome is a condition in which the immune system mistakenly creates antibodies that attack tissues in the body. These antibodies can cause blood clots to form in arteries and veins. Blood clots can form in the legs, lungs and other organs, such as the kidneys and spleen.
The presence of an antiphospholipid antibody such as the lupus anticoagulant and anticardiolipin antibody in an individual is associated with a predisposition for blood clots. Blood clots can form anywhere in the body and can lead to stroke, gangrene, heart attack, and other serious complications.
Cardiolipin Antibodies (IgA, IgG, IgM) - Cardiolipin antibodies (CA) are seen in a subgroup of patients with autoimmune disorders, particularly systemic lupus erythematosus (SLE), who are at risk for vascular thrombosis, thrombocytopenia, cerebral infarct and/or recurrent spontaneous abortion.
1 mL citrated plasma collected in a 3.2% sodium citrate (light blue-top) tube
Anticardiolipin antibodies, IgA, quantitative; anticardiolipin antibodies, IgG, quantitative; anticardiolipin antibodies, IgM, quantitative
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
ACA can often be observed during the convalescent phase of acute bacterial and viral infections and in individuals with syphilis. These infection-induced antibodies are usually transient and are not associated with an increased risk of clinical complications.
Enzyme-linked immunosorbent assay (ELISA) detecting isotype-specific ACA binding to a microtiter plate coated with purified cardiolipin antigen
Individuals with the antiphospholipid antibody syndrome (APS) have an increased risk for stroke, myocardial infarction, venous thrombosis, thromboembolism, thrombocytopenia, and/or recurrent miscarriages.
1. Wilson WA, Gharavi AE, Koike T, et al. International Consensus Statement on Preliminary Classification Criteria for Definite Antiphospholipid Syndrome: Report of an International Workshop. Arthritis Rheum. 1999; 42 (7):1309-1311. PubMed 10403256